Background and objectives Development of functional B cell niches in peripheral tissues has been associated to chronicity and pathologic severity in different human conditions such as kidney allograft rejection and multiple sclerosis. Ex vivo studies in the rheumatoid arthritis (RA)-severe combined immunodefi ciency mouse chimera model advocate a role for the synovial B cell compartment in enhancing local immune responses though production of auto-antibodies and by promoting local T cell activation. The aim of this study was to investigate the relationship between the degree of B cell infi ltration and activation in the joint and clinico-pathologic variability in patients with RA. Methods Synovial tissues from 66 RA patients were evaluated by immunohistochemistry (IHC). 25 paired paraffi n and RNA samples were used for comparative IHC and quantitative PCR. B cell infi ltration was assessed semi-quantitatively (0-3) based on the size and density distribution of CD20 B cell aggregates and through quantitative evaluation of mRNA expression of activation-induced cytidine deaminase (AID), the enzyme required for immunoglobulin affi nity maturation and class switching. B cell scores and AID expression levels were correlated to clinical and bio-molecular parameters of immune cell activation, disease activity and bone remodelling. Results The IHC CD20 B cell score was signifi cantly related to the expression levels of CXCL13 (p=0.001) and lymphotoxin β (p=0.004). The degree of B cell aggregation tightly
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